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RNase L controls terminal adipocyte differentiation, 
lipids storage and insulin sensitivity via CHOP10 
mRNA regulation
0 Fabre1, T Salehzada1, K Lambert1, Y Boo Seok2, A Zhou2, J Mercier1,2,3 and C Bisbal*’1
Adipose tissue structure is altered during obesity, leading to deregulation of whole-body metabolism. Its function depends on 
its structure, in particular adipocytes number and differentiation stage. To better understand the mechanisms regulating 
adipogenesis, we have investigated the role of an endoribonuclease, endoribonuclease L (RNase L), using wild-type and RNase 
L-knockout mouse embryonic fibroblasts (RNase L^ -MEFs). Here, we identify C/EBP homologous protein 10 (CHOP10), a 
dominant negative member of the CCAAT/enhancer-binding protein family, as a specific RNase L target. We show that RNase L 
is associated with CHOP10 mRNA and regulates its stability. CHOP10 expression is conserved in RNase L /_-MEFs, maintaining 
preadipocyte state while impairing their terminal differentiation. RNase L /_-MEFs have decreased lipids storage capacity, 
insulin sensitivity and glucose uptake. Expression of ectopic RNase L in RNase L_/ -MEFs triggers CHOP10 mRNA instability, 
allowing increased lipids storage, insulin response and glucose uptake. Similarly, downregulation of CHOP10 mRNA with 
CHOP10 siRNA in RNase L /_-MEFs improves their differentiation in adipocyte. In vivo, aged RNase L“/“ mice present an 
expanded adipose tissue, which, however, is unable to correctly store lipids, illustrated by ectopic lipids storage in the liver and 
in the kidney. These findings highlight RNase L as an essential regulator of adipogenesis via the regulation of CHOP10 mRNA. 
Cell Death and Differentiation (2012) 19, 1470-1481; doi:10.1038/cdd.2012.23; published online 23 March 2012
In the past 50 years, the incidence of obesity and related 
metabolic disorders has increased markedly, reaching a 
worldwide epidemic scale. Obesity is associated with several 
health problems, including insulin resistance, type 2 diabetes, 
fatty liver disease, atherosclerosis, degenerative disorders, 
airway diseases and some cancers.
Obese individuals suffer from a higher adiposity level 
resulting from an increased adipocytes number (hyperplasia) 
and/or size (hypertrophy).1 Adipose tissue is involved in 
metabolic regulation and particularly lipids storage, insulin 
sensitivity and glucose uptake.2 It has therefore a central role 
in controlling whole-body glucose and lipids homeostasis. 
Adipose tissue functions depend on its structure defined 
by adipocytes number and differentiation stage; this structure 
is altered during obesity.3 Understanding the mechanisms 
implicated in the regulation of adipocyte differentiation should 
help elucidate adipose tissue development and its link to 
metabolic diseases.
After activation by various factors, such as hormones, 
adipogenesis occurs in successive phases leading from 
preadipocytes to mature adipocytes. Particularly, the expan­
sion phase of preadipocytes precedes their differentiation to
adipocytes.4,5 Like other differentiation pathways, adipogen- 
esis involves sequential and orderly expression of many 
factors triggering a whole activation/inactivation cascade of 
genes expression. Among the several transcription factors 
known to have a significant role in promoting adipogenesis, 
two of them have a central role by regulating several 
downstream target genes: the CCAAT/enhancer-binding 
protein a (C/EBPa) and the nuclear receptor peroxisome 
proliferator-activated receptor γ2 (PPARγ2). C/EBPα and 
PPARγ2 expression and activity are required for the adipose 
tissue development, insulin sensitivity and maintenance of 
mature adipocyte functions, such as triglycerides synthesis 
and storage. Their expression is closely regulated at different 
levels; in particular, their transcription is regulated by other 
members of the C/EBP family (β,δ),6 which expression 
precedes the induction of C/EBPα and PPARγ2. Terminal 
adipogenesis is also regulated by another C/EBP family 
member named C/EBP homologous protein 10 (CHOP10). 
By forming heterodimers with other C/EBPs, CHOP10 
functions as a dominant negative member of the C/EBP 
family. In preadipocytes, it forms a heterodimer with C/EBPβ, 
inhibiting its DNA-binding activity. This inhibition of C/EBP// is
necessary for the expansion phase of preadipocytes before 
terminal differentiation.7 Thus, downregulation of CHOP10 
allows C/EBPβ release and the transactivation of C/EBPα and 
PPARγ, which expression is essential for terminal adipocyte 
differentiation and the expression of most genes characteriz- 
ing fat cells.7 Moreover, CHOP10 has been implicated in the 
production of reactive oxygen species (ROS),8 important 
regulators of adipocyte differentiation and insulin response.9
As now demonstrated by several studies, an essential 
mechanism of gene expression control is through mRNA 
stability regulation.10,11 One nuclease firmly implicated in 
cellular mRNA stability is the endoribonuclease L (RNase 
L).12 RNase L is an ubiquitous endoribonuclease, which 
activity is strictly dependent on an oligoadenylate, the 2-5A, 
synthesized by the 2-5A synthetase(s).12,13 RNase L reg- 
ulates mRNAs stability during their translation and its activity 
is negatively regulated by RLI (RNase L inhibitor).14-16 We 
have previously shown that RNase L and its inhibitor RLI are 
induced during differentiation and control gene expression 
and cell fate during myogenesis.11,17 Transcriptome analysis 
of myoblasts overexpressing RNase L allowed us to identify 
some mRNA targets of RNase L, among which CHOP10 
mRNA.11 As CHOP10 is a conductor of adipogenesis,7 we 
were interested in studying the role of RNase L in adipogen- 
esis and insulin sensitivity. Hence, we used wild-type (WT) 
and RNase L-knockout mouse embryonic fibroblasts 
(MEFs),18 adipogenesis of MEFs induced by hormonal 
treatment being a well-established model system for the 
study of adipocyte differentiation.19 Here, we show that 
RNase L directly regulates CHOP10 mRNA. Indeed, we 
demonstrate that RNase L is associated with CHOP10 mRNA 
and controls CHOP10 expression by regulating its mRNA 
stability. As CHOP10 expression is maintained after induction 
of adipocyte differentiation in RNase L-/--MEFs, this leads 
to the impairment of terminal adipocyte differentiation, the 
decrease in insulin sensitivity and glucose uptake, and to 
increased ROS production. Conversely, expression of ectopic 
human RNase L (Hu-RNase L) or transfection of CHOP10- 
siRNA (siCHOP) in RNase L-/--deficient cells triggers 
CHOP10 mRNA instability, decreases ROS level and allows 
an increase in lipids storage, insulin response and glucose 
uptake. Consolidating these results, RNase L-/- mice present 
an expansion of their adipose tissue (hyperplasia) and a 
defect in lipids storage. Our results highlight RNase L as an 
essential regulator of the adipogenesis processes and insulin 
response by regulating CHOP10 mRNA stability.
Results
Lack of RNase L impairs adipogenesis. MEFs are 
interesting cell models to study the specific role of a factor 
during adipogenesis, as they can differentiate into mature 
adipocytes after hormonal stimulation.19 To explore RNase L 
function during adipogenesis at a molecular level, we 
used WT-MEFs and RNase L-knockout MEFs (RNase 
L-/--MEFs).18
RNase L-/--MEFs did not express mouse RNase L protein, 
as the first exon of RNase L gene was deleted in the RNase 
L-/- mouse.18 However, these cells expressed an equivalent
level of RLI as WT-MEFs (Figure 1A). WT-MEFs and RNase 
L-/--MEFs present the same viability under our experimental 
conditions, as shown in Figure 1B.
First, we compared lipids accumulation in WT-MEFs and 
RNase L-/--MEFs before and after adipocyte differentiation. 
If WT-MEFs and RNase L-/--MEFs both increased their lipids 
content after differentiation (Figure 1C, compare a and e to b 
and f, respectively), their lipids staining with oil red O showed a 
very different pattern. Indeed, when observed at a lower 
magnification, lipids staining in WT-MEFs was not uniform, 
small groups of highly labeled cells being separated by 
unlabeled cells (Figure 1C, c). On the other hand, lipids 
staining in RNase L-/--MEFs revealed a low but uniform 
labeling of cells, indicating that more cells accumulated lipids 
(Figure 1C, d). However, observation of lipids staining 
at a greater magnification showed that RNase L-/--MEFs 
accumulated smaller lipid droplets than WT-MEFs (Figure 1C, 
compare e and f). This difference in lipids accumulation was 
confirmed by quantification: RNase L-/--MEFs accumulated 
1.7 time lesser lipids than WT-MEFs (Figure 1D). This 
impairment in lipids storage, a major adipocyte function, was 
confirmed by studying expression of two proteins specifically 
expressed in mature adipocytes: adipocyte protein 2 (aP2)/ 
fatty acid-binding protein 4 (Fabp4), involved in intracellular 
lipids trafficking,20 and perilipin, a lipid droplet-associated 
protein21 (Figure 2A). As illustrated in Figure 2A, aP2/Fabp4 
is less expressed in RNase L-/--MEFs than in WT-MEFs 
(compare Figure 2A, a and b). Surprisingly, even if we 
observed an increase in lipids accumulation after differentia- 
tion of RNase L-/--MEFs (Figures 1C and D), we were unable 
to detect perilipin surrounding lipid droplets in these cells 
(compare Figure 2A, c and d). The same result was obtained 
by western blot, using an anti-perilipin antibody (data 
not shown). These results indicated impairment in lipids 
accumulation and storage in RNase L-/--MEFs.
Genes expression during adipocyte differentiation.
Adipogenesis involves a differentiation switch that activates 
a new program of gene expression. As previously shown 
during myoblast differentiation,11 RNase L activity is induced 
throughout adipocyte differentiation of WT-MEFs. Indeed, 
OAS2 (oligoadenylate synthetase 2) mRNA is induced 
(Figures 2B and C); OAS2 synthesizes the 2-5A allowing 
RNase L activation.12,13 In parallel, RLI mRNA expression is 
decreased 6 days after induction of adipocyte differen- 
tiation. To explore the molecular basis through which RNase 
L deficiency impairs adipogenesis, we also followed 
expression levels of mRNAs coding for factors involved in 
adipogenesis (C/EBPtz, CHOP10 and PPARy2), lipids 
metabolism (aP2/Fabp4) and insulin response (Glut4: 
glucose transporter 4; Figures 2B and C). The expression 
profiles of these mRNAs during the differentiation were 
modified in RNase L-/--MEFs compared with WT-MEFs. 
Induction of C/EBPα, aP2/Fabp4 and PPARγ2 was much 
lower in RNase L-/--MEFs. Importantly, Glut4 mRNA was 
not induced in the absence of RNase L but increased >10 
times in WT-MEFs. Contrarily, CHOP10 mRNA expression 
was maintained at a high level during the differentiation in 
RNase L-/--MEFs as it declined >70% in WT-MEFs from 
confluence to day 6 of differentiation (Figures 2B and C).
Figure 1 RNase L and RLI expression, viability and lipids accumulation in WT-MEFs and RNase L ' -MEFs. (A) WT-MEFs and RNase L ' -MEFs proteins were 
analyzed by western blot with antibodies against mouse RNase L and mouse RLI. α-tubulin antibody was used as an indicator of proteins quantity loading. (B) Cells viability 
was measured in WT-MEFs and RNase L ' -MEFs by measuring fluorescence emission at 615nm of PrestoBlue reagent reduced by living cells. Error bars refer to the S.D. 
obtained in four independent experiments. (C) WT-MEFs and RNase L -MEFs were induced to differentiate in ADM. Cells were fixed and stained with oil red 0 to reveal 
lipids accumulation at day 0 (a and b) and after 6 days of differentiation (c-f). Cells were observed at a magnification of x 40 (a, b, e and f) or x 5 (c and d). Arrows in (c) 
indicate groups of differentiated cells observed at upper magnification ine. (D) After staining with oil red O, lipids were quantified in WT-MEFs and RNase L -MEFs at day 0 
(ND) and day 6 after induction of adipocyte differentiation (D) by spectrophotometric analysis at 540 nm, following elution of cell retained oil red O with ethanol. The amount of 
lipids in WT-MEFs at day 0, was set to 100%. Error bars refer to the S.D. obtained in four independent experiments conducted in duplicate. **P=0.009 RNase L -MEFs 
compared with WT-MEFs at day 6
ROS production. In RNase L_/_-MEFs, we noted a higher 
CHOP10 expression than in WT-MEFs (Figures 2B and C). 
This constant expression of CHOP10 could favor increased 
ROS production.22,23 Indeed, as shown in Figure 2D, the 
level of ROS was significantly higher in RNase L '--MEFs 
compared with WT-MEFs.
RNase L is associated with CHOP10 messenger- 
ribonucleoprotein complex (mRNP) and regulates 
CHOP10 mRNA stability. We were particularly interested 
in the differential CHOP10 mRNA expression that we noticed 
between WT-MEFs and RNase L_/_-MEFs, CHOP10 being, 
as described in the introduction, an essential regulator of 
adipogenesis. RNase L has no great sequence specificity 
and cleaves single-stranded RNA at UpNp sequences.12 
Moreover, RNase L has no specific RNA recognition motif 
sequence allowing its direct interaction with mRNA. 
However, we have previously shown that RNase L could 
participate to mRNPs via its interaction with RNA-binding 
proteins.15 To analyze if RNase L is associated with mRNP 
containing CHOP10 mRNA, we immunoprecipitated 
cytoplasmic mRNPs with a specific monoclonal antibody 
raised against RNase L in RNase L '--MEFs and WT-MEFs 
cell extracts. By real-time quantitative PCR (q-PCR), we 
could specifically amplify and detect CHOP10 mRNA in the 
mRNPs immunoprecipitated with a specific antibody against 
RNase L (Figure 3a). The presence of RNase L protein 
associated with CHOP10 mRNA was only observed in
WT-MEFs and no interaction between RNase L and 
CHOP10 mRNA could be identified without any antibody or 
using an irrelevant antibody (α-tubulin; Figure 3a). These 
results confirmed the specificity of the constated interaction. 
To confirm that RNase L regulates CHOP10 mRNA stability, 
we then compared CHOP10 mRNA stability in WT-MEFs 
and RNase L_/_-MEFs after transcription inhibition by the 
actinomycin D treatment. In RNase L_/_-MEFs, we clearly 
observed a stabilization of CHOP10 mRNA compared with 
WT-MEFs (Figures 3b and c).
Insulin response. RNase L“'_-MEFs presented altered 
adipocyte properties such as lipids accumulation (Figures 
1C, D and 2A), Glut4 expression (Figures 2B and C) and a 
higher ROS level (Figure 2D) compared with WT-MEFs. 
All these features are indicative of lower insulin response in 
RNase -MEFs. So we measured Akt phosphorylation at 
serine 473 (Ser473) before and after insulin treatment of 
WT-MEFs and RNase L_/_-MEFs. Akt phosphorylation was 
significantly lower in RNase L_/_-MEFs than in WT-MEFs 
(Figures 4a and b). Akt phosphorylation is crucial for the 
intracellular signal transduction of insulin leading to glucose 
uptake by adipocytes.24 Measurement of glucose uptake in 
RNase L -MEFs also showed a defect in insulin response 
of these cells compared with WT-MEFs (Figure 4c). Indeed, 
no increase in glucose uptake after insulin treatment of 
RNase L -MEFs was observed while it was increased two 
times in WT-MEFs after insulin treatment. Glucose uptake
Figure 2 RNase L deficiency impairs adipocyte functions. (A) WT-MEFs and RNase L ' -MEFs were induced to differentiate in ADM. Cells were fixed at day 6 after 
induction of adipocyte differentiation and then incubated with an antibody against aP2/Fabp4 (red; WT-MEFs, (a) and RNase L -MEFs. (b) and perilipin (red; WT-MEFs, 
(c) and RNase L 7 -MEFs, (d)). DNA was stained with DAPI (blue). Cells were observed at a magnification of x 40. Arrow in (c) indicates perilipin surrounding lipid droplets. 
(B) Confluent WT-MEFs and RNase L 7 -MEFs were induced to differentiate in ADM. mRNAs were extracted at confluence (C) and at days 3 (3d) and 6 (6d) after switch to 
ADM. Following RT and PCR amplification using specific primers (Supplementary Table 1), PCR products were analyzed on 1.2% agarose gel. Pictures of the gels are shown. 
NE, non expressed. (C) After RT, mRNA expression was then measured by q-PCR. Sample data were analyzed according to the comparative cycle threshold method and 
were normalized by stable reference expression of EEF1α gene. For each mRNA, the level of expression at confluence was set at 100% in WT-MEFs allowing on one side a 
comparison between WT-MEFs (black bars) and RNase L 7 -MEFs (white bars) for each phase of the differentiation and, on the other side, a comparison between the 
different phases of the differentiation in each cell line. Error bars refer to the S.D. obtained in four independent experiments conducted in duplicate. *P<0.05, **P< 0.01 and 
SP< 0.001. (D) ROS level was measured by NBT reduction in WT-MEFs and RNase L ' -MEFs at confluence. Data are expressed relative to ROS level in WT-MEFs, which 
was set at 100%. Error bars refer to the S.D. obtained in three independent experiments conducted in duplicate. 0.001 ROS level in RNase L 7 -MEFs compared with 
WT-MEFs
was equivalent in WT-MEFs and RNase L_/_-MEFs without 
insulin treatment (data not shown). This basal glucose 
uptake in the absence of insulin would be due to Glut1 
activity, being that WT-MEFs and RNase L '--MEFs 
expressed similarly this glucose receptor (data not shown).
Ectopic expression of RNase L in RNase L 7 -MEFs 
restored terminal adipocyte differentiation. To verify that 
the impairment of adipocyte differentiation observed in 
RNase L_/_-MEFs was specifically due to the absence of 
RNase L, we generated RNase L_/_-MEFs-based stable cell 
lines by transfection with an empty pcDNA3 vector (V-RNase 
L-7--MEFs) or with a vector containing Hu-RNase L
complementary DNA (cDNA; Hu-RNase L_/_-MEFs; 
Figure 5a).
Interestingly, ectopic expression of RNase L restored high 
expression of C/EBPa, aP2/Fabp4, PPARγ2 and Glut4 mRNA 
during adipocyte differentiation of Hu-RNase L_/_-MEFs. 
Moreover, RNase L expression led to a decreased CHOP10 
mRNA level during differentiation of these cells (Figures 5b 
and c). Actinomycin D experiments in V-RNase L '--MEFs 
and Hu-RNase L -MEFs confirmed that this downregulation 
of CHOP10 mRNA was due to a decrease of its stability 
(Figure 5d). Beside, this lower CHOP10 mRNA level was 
accompanied by a reduced ROS level (Figure 5e). Moreover, 
lipids accumulation (Figure 6A), insulin response (Figures 6B 
and C) and glucose uptake (Figure 6D) were also significantly
Figure 3 RNase L is associated with CHOP10 mRNP and specifically degrades 
CHOP10 mRNA. (a) CHOP10 mRNA interaction with RNase L was evaluated by 
RNPs immunoprecipitation in WT-MEFs and RNase L ' -MEFs. Upper panel 
represents western blot analysis with an antibody against RNase L of total cell 
extract (TE), and RNPs immunoprecipitated with no antibody (C), anti-a-tubulin 
antibody (T) or anti-RNase L antibody (R). Lower panel represents CHOP10 mRNA 
expression after RNAs extraction from RNPs immunoprecipitated with no antibody 
(C), anti-α-tubulin antibody (T) or anti-RNase L antibody (R) and after RT then 
q-PCR amplification with specific CHOP10 mRNA primers (Supplementary Table 1). 
q-PCR products were analyzed on 1.2% agarose gel. Photographies of the gels are 
shown. RNPs immunoprecipitation in WT-MEFs and RNase L 7 -MEFs, followed 
by western blot analysis, RT and q-PCR was realized on two independent 
experiments. (b) WT-MEFs and RNase L -MEFs were treated with actinomycin 
D, then cells were collected at the indicated time points and mRNAs were analyzed, 
after RT, by PCR amplification with specific primers of EEF1α and CHOP10. 
PCR products were analyzed on 1.2% agarose gel. Pictures of the gels are shown. 
(c) cDNAs obtained for analysis of mRNA stability after the actinomycin D treatment 
were then used for quantification by q-PCR. Sample data were analyzed according 
to the comparative cycle threshold method and were normalized by stable reference 
expression of EEF1α gene. Levels of CHOP10 mRNA expression were set at 100% 
at time 0 in WT-MEFs (♦) and RNase L 7 -MEFs (□). Error bars refer to the S.D. 
obtained in four independent experiments conducted in duplicate. *P<0.05
improved in Hu-RNase L ' -MEFs compared with V-RNase 
L_/_-MEFs in differentiated cells.
Downregulation of CHOP10 mRNA in RNase L 7 -MEFs 
improves their adipocyte differentiation. To confirm that 
regulation of CHOP10 expression by RNase L is key for 
adipocyte differentiation, we then downregulated expression
of CHOP10 mRNA by siCHOP in RNase L-/--MEFs. RNase 
L_/_-MEFs were transfected with siCHOP or a control siRNA 
(siCT) before induction of differentiation. Only a certain 
percentage of the cells population was transfected by the 
siCHOP, as checked by using a fluorescent siRNA (data 
not shown). However, we could observe a downregulation of 
CHOP10 mRNA in RNase L_/_-MEFs transfected with 
siCHOP compared with RNase L 7_-MEFs transfected with 
siCT (Figure 7A). This allowed a better terminal adipocyte 
differentiation of RNase L /_-MEFs, as demonstrated by an 
increase in lipids accumulation and the detection of perilipin 
surrounding lipid droplets in RNase L_/~-MEFs transfected 
with siCHOP compared with RNase L_/_-MEFs transfected 
with siCT (Figures 7B and C). We also observed a slight 
improvement in insulin response, as shown by a small 
increase of Akt phosphorylation at Ser473 in RNase L_/_- 
MEFs transfected with siCHOP compared with RNase L_/_- 
MEFs transfected with siCT (Figures 7D and E). However, 
this result was not statistically significant. The latter could be 
because of the difficulty to obtain sufficient cells transfected 
with siCHOP. Nevertheless, these results clearly showed 
that CHOP10 mRNA downregulation is necessary to allow 
complete adipocyte differentiation of MEFs.
Discussion
Adipose tissue has a central role in metabolic regulations, 
partly due to its capacity to store lipids. Adipogenesis is 
controlled by several functionally coherent mechanisms, 
which are intricately coordinated and regulated in time to 
ensure the activation/inactivation cascade of genes expres- 
sion. The transition from preadipocyte to mature adipocyte 
involves successive stages: growth arrest, clonal expansion 
and differentiation. The clonal expansion phase is necessary 
for terminal differentiation. These different steps are pre- 
dominantly regulated by C/EBP family members and PPARγ.
Regulation of mRNA stability is an essential mechanism for 
controlling genes expression.10,11 Cytoplasmic mRNAs are 
engaged in mRNA/proteins complexes called mRNPs, which 
have a major role in mRNA translation and stability.25 Here, 
we show that an endoribonuclease, RNase L, directly 
regulates mRNA stability of CHOP10, a member of the 
C/EBP family and a fundamental regulator of adipogenesis. 
RNase L has no great sequence specificity and cleaves 
single-stranded RNA at UpNp sequences.12 RNase L speci- 
ficity is above all due to its interaction with transacting factors, 
such as eukaryotic releasing factor 315 and mitochondrial 
initiation factor 2.16 In this study, we show for the first time that 
RNase L interacts with CHOP10 mRNA in mRNPs. Indeed, a 
specific monoclonal antibody directed against RNase L 
immunoprecipitated RNase L protein associated with 
CHOP10 mRNA only in WT-MEFs, while no RNase 
L-CHOP10 mRNA interaction was detected in RNase L_/_- 
MEFs. Association of RNase L with CHOP10 mRNA in mRNP 
enables CHOP10 mRNA regulation by RNase L, as illustrated 
by the preservation of CHOP10 mRNA expression in RNase 
L_/_-MEFs when it strongly decreases in WT-MEFs during 
adipocyte differentiation.
CHOP10 interacts with another member of the C/EBP 
family, C/EBPβ, by inhibiting its transcriptional activity. This
inhibition is necessary for clonal expansion of preadipocytes, 
a prerequisite to adipocyte differentiation.7 As CHOP10 
expression decreases, C/EBPβ is released, allowing trans- 
activation of C/EBPa and terminal adipocyte differentiation. 
Maintaining CHOP10 expression could lead to an excessive 
clonal expansion (hyperplasia), at the expense of late 
differentiation and lipids storage capacity of mature adipo- 
cytes. Here, we show that terminal adipocyte differentiation is 
impaired in RNase L_/_-MEFs. In fact, these cells accumu- 
lated fewer lipids than WT-MEFs. Moreover, RNase L_/_- 
MEFs expressed a lower level of aP2/Fabp4, indicating a 
dysfunction of intracellular lipids trafficking.20 Beside, we
failed to detect perilipin at the surface of lipid droplets of 
RNase L_/_-MEFs. In RNase L_/_-MEFs, CHOP10 expres- 
sion was maintained even after induction of differentiation, 
leading to lower induction of C/EBPa and PPARγ2 expression. 
Therefore, as terminal adipocyte differentiation could not 
correctly proceed, we observed more adipocytes with small 
lipid droplets while lipids accumulation, Glut4 mRNA expres- 
sion and insulin response were lower in these cells than in 
WT-MEFs. On the other hand, it has been shown in different 
cell systems that overexpression of CHOP10 leads to an 
increased ROS production.26 ROS, in turn, could induce 
CHOP10 expression.27 Actually, in RNase L_/_-MEFs cells, 
we noticed an increase in ROS level. Several studies relating 
to the consequences of ROS production have been performed 
and contradicting effects have been reported. Some studies 
describe ROS as positive regulators of adipocyte differentia- 
tion by accelerating mitotic clonal expansion28 and enhancing 
insulin sensitivity.29 Conflictingly, other studies present 
ROS as inhibitors of adipocyte differentiation by regulating 
CHOP10 expression27 and inhibiting insulin response22 and 
Glut4 expression.30 The apparent discrepancies between 
these different studies reflect how the level and kinetics of 
ROS expression have vital effects on cell fate.9 Here, we 
showed higher ROS level in RNase L_/_-MEFs with a 
decrease in insulin signaling, which participated in insulin- 
stimulated glucose uptake inhibition. The lower level of Glut4 
expression in RNase L 7_-MEFs could also favor the 
restricted glucose uptake.
To confirm the essential role of RNase L in CHOP10 mRNA 
regulation and adipogenesis, we re-introduced RNase L 
expression in RNase L ^-MEFs. In these cells, which express 
Hu-RNase L (Hu-RNase L^’-MEFs), CHOP10 mRNA stability 
was highly reduced compared with RNase L /_-MEFs 
transfected with a control vector (V-RNase L_/_-MEFs). This 
also led to a decreased CHOP10 mRNA expression after 
induction of adipocyte differentiation and to higher levels of C/ 
EBPα, PPARγ2, aP2/Fabp4 and Glut4 mRNAs expression. 
Moreover, in Hu-RNase L_/_-MEFs, ROS level were de- 
creased by 50%, while lipids accumulation was increased by 
75%. Finally, insulin response and glucose uptake were also 
significantly improved after re-expression of RNase L in
◄---------------------------------------------------------------
Figure 4 insulin response, (a) WT-MEFs and RNase L z -MEFs were treated 
(+) or not (-) 10 min at 37 °C with insulin at confluence (ND) or after 6 days of 
differentiation (D). Total cellular extracts were analyzed by western blot with anti-P- 
Akt (Ser473), anti-Akt and anti-α-tubulin antibodies. (b) Protein bands shown in (a) 
were quantified with the ImageJ software. The levels of P-Akt (Ser473)/Akt were 
corrected with corresponding α-tubulin levels, used as indicator of proteins loading. 
P-Akt (Ser^/Akt rate in WT-MEFs and RNase L ' -MEFs before insulin treatment 
was set at 1. Error bars refer to the S.D. obtained in four independent experiments 
conducted in duplicate. *P=0.024 P-Akt (Ser473)/Akt level after insulin treatment in 
differentiated RNase L-MEFs compared with WT-MEFs. (c) Glucose uptake was 
measured in WT-MEFs and RNase L 7 -MEFs. Differentiated cells were incubated 
(+) or not (-) with insulin then medium was changed to DMEM without glucose 
and with 6-NBDG. After a 45-min incubation at 37 C, fluorescence intensity of 
6-NBDG was measured at 540 nm wavelength (465 nm excitation wavelength). 
Glucose uptake represents the ratio of fluorescence measured in basal condition 
(without insulin) and with insulin. Fluorescence values were normalized by cell 
number. Error bars refer to the S.D. obtained in three independent experiments 
conducted in duplicate. *P=0.011 insulin-stimulated glucose uptake level in 
differentiated RNase L -MEFs compared with WT-MEFs
Figure 5 Ectopic expression of Hu-RNase L in RNase L ' -MEFs. (a) Hu-RNase L expression was measured in V-RNase L ' -MEFs (V-RNase L' ) and Hu-RNase 
L-MEFs (Hu-RNase L 1 ) by western blot using a specific antibody against Hu-RNase L. (b) Confluent V-RNase L 1 -MEFs and Hu-RNase L -MEFs were induced to 
differentiate in ADM. mRNAs were extracted at confluence (C) and at days 3 (3d) and 6 (6d) after switch to ADM. After RT and PCR amplification using specific primers 
(Supplementary Table 1), PCR products were analyzed on 1.2% agarose gel. Pictures of the gels are shown. (c) After RT, mRNA expression was measured by q-PCR. 
Sample data were analyzed according to the comparative cycle threshold method and were normalized by stable reference expression of EEF1α gene. For each mRNA, 
the level of expression at confluence was set at 100% in V-RNase L'-MEFs. allowing on one side a comparison between V-RNase L 7 -MEFs (black bars) and Hu-RNase 
L 7 -MEFs (white bars) for each phase of the differentiation and, on the other side, a comparison between the different phases of the differentiation in each cell line. Error bars 
refer to the S.D. obtained in four independent experiments conducted in duplicate. *P<0.05, **P<0.01 and sSP<0.001. (d) At confluence, V-RNase L 7 -MEFs and Hu- 
RNase L 7 -MEFs were treated with actinomycin D, then cells were collected at the indicated time points and mRNA expression was quantified, after RT, by q-PCR. Sample 
data were analyzed according to the comparative cycle threshold method and were normalized by stable reference expression of EEF1α gene. Levels of CHOP10 mRNA 
expression were set at 100% at time 0 in V-RNase L-MEFs (♦) and Hu-RNase L -MEFs (□). Error bars refer to the S.D. obtained in four independent experiments 
conducted in duplicate. *P<0.05, **P<0.01. (e) ROS level was measured by NBT reduction in V-RNase L 7 -MEFs and Hu-RNase L 7 -MEFs at confluence. Data are 
expressed relative to ROS level in V-RNase L 7 -MEFs, which was set at 100%. Error bars refer to the S.D. obtained in three independent experiments conducted 
in duplicate. **P= 0.002 ROS level in Hu-RNase L 7 -MEFs compared with V-RNase L 7 -MEFs
RNase L_/_-MEFs. However, we could not completely 
reverse RNase L_/_-MEFs phenotype to WT-MEFs with 
Hu-RNase L transfection. One reason could be that 
transfected RNase L mRNA was not regulated as was the 
endogenous RNase L mRNA in WT-MEFs. RNase L expres- 
sion is constitutive in Hu-RNase L_/_-MEFs, and RNase L 
activity could only be regulated by OAS2 expression, 2-5A 
synthesis and RLI.
To confirm the effects observed following the overexpres- 
sion of CHOP10 on RNase L/_-MEFs differentiation inhibi- 
tion, we downregulated CHOP10 mRNA in RNase L_/_-MEFs 
by CHOP10 siRNA (siCHOP) transfection. Even if not all cells 
were transfected with siCHOP, we notified a significant
downregulation of CHOP10 mRNA expression, which was 
accompanied by improved adipocyte differentiation. Our 
results clearly identify RNase L as an essential effector of 
terminal adipocyte differentiation by regulating CHOP10 level.
Maintaining a high level of CHOP10 expression in vivo 
could lead to an excessive clonal expansion (hyperplasia) of 
developing adipocytes at the expense of late differentiation 
and lipids storage capacity of mature adipocytes.5 Actually, 
RNase L_/_ mice possess a higher number of smaller 
adipocytes than WT mice (Figure 8A), that is characteristic 
of hyperplasia.31 This number of adipocytes increases with 
aging, as we observed an adipose tissue expansion in aged 
RNase L_/' mice. The average body weight of aged RNase
Figure 6 Lipids accumulation and insulin response after re-introduction of RNase L expression in RNase L 7 -MEFs. (A) V-RNase L 7 -MEFs (a) and Hu-RNase L - 
MEFs (b) were induced to differentiate in ADM. Cells were fixed and stained with oil red 0 to reveal lipids accumulation after 6 days of differentiation. Cells were observed at a 
magnification of x 40. After staining, lipids were quantified by spectrophotometric analysis at 540 nm following elution of cell retained oil red 0 with ethanol. The amount of 
lipids in V-RNase L -MEFs was set at 100%. Error bars refer to the S.D. obtained in four independent experiments conducted in duplicate. **P=0.005 lipids quantity in Hu- 
RNase L'-MEFs compared with V-RNase L-MEFs. (B) V-RNase L 7 -MEFs and Hu-RNase L 7 -MEFs were treated ( + ) or not (-) 10 min at 37 °C with insulin at 
confluence (ND) or after 6 days of differentiation (D). Total cellular extracts were analyzed by western blot with anti-P-Akt (Ser473), anti-Akt and anti-α-tubulin-specific 
antibodies. (C) Protein bands shown in (B) were quantified with the ImageJ software. The levels of P-Akt (Ser473)/Akt were corrected with corresponding α-tubulin levels, used 
as indicator of proteins loading. P-Akt (Ser473)/Akt rate in V-RNase L'-MEFs and Hu-RNase L 7 -MEFs before insulin treatment was set at 1. Error bars refer to the S.D. 
obtained in four independent experiments. *P= 0.05 P-Akt (Ser473)/Akt level after insulin treatment in differentiated Hu-RNase L'-MEFs compared with differentiated V- 
RNase L 7 -MEFs. (D) Glucose uptake was measured in V-RNase L 7 -MEFs and Hu-RNase L'-MEFs after differentiation. Cells were incubated (+) or not (-) with 
insulin, then medium was changed to DMEM without glucose and 6-NBDG. After a 45-min incubation at 37 C, fluorescence intensity of 6-NBDG was measured at 540 nm 
wavelength (465 nm excitation wavelength). Glucose uptake represents the ratio of fluorescence measured in basal condition (without insulin) and in the presence of insulin. 
Fluorescence values were normalized by cell number. Error bars refer to the S.D. obtained in three independent experiments conducted in duplicate. *P=0.028 insulin- 
stimulated glucose uptake level in differentiated Hu-RNase L -MEFs compared with V-RNase L'-MEFs
L_/_ mice was 21% higher than that of aged WT mice 
(Figure 8B). Despite this excessive adipose tissue develop- 
ment, RNase L_7 mice present a defect in lipids storage, as 
indicated by ectopic fat depots in other organs, such as the 
liver and the kidneys. Indeed, RNase L_/_ mice present 
hepatic steatosis and lipid droplets within renal tubular 
epithelial cell cytoplasms (Figure 8C). Interestingly, adipose 
tissue expansion is observed in aged RNase L_/_ mice and 
not in young mice. At present, it is known that CHOP10 is 
more expressed in old individuals preadipocytes than from 
young ones.5 Change in adipogenesis process is due to the 
incapacity of preadipocytes to express appropriate levels of 
key adipogenic regulators: CHOP10, C/EBPa and PPARy.4,32 
We assume that overexpression of CHOP10 in RNase L_/_ 
mice added to the physiological overexpression of CHOP10 in 
old age would lead to even higher levels of CHOP10. In the 
aged RNase L_/_ mice, this cumulative effect would increase 
hyperplasia of adipose tissue at the expense of its terminal 
differentiation and efficient lipids storage.
Interestingly, Tomaru et al.33 recently produced a trans- 
genic mouse with decreased proteasomal chymotrypsin-like 
activity. These mice overexpressed RNase L and presented a 
loss of adipose tissue.
Here, we identify RNase L as a regulator of adipogenesis by 
regulating CHOP10 mRNA stability. As cited above and 
demonstrated in vivo by others, CHOP10 has a main role in 
the regulation of adipose tissue expansion by controlling the 
proliferation phase of preadipocytes. The decrease of RNase 
L activity, through excessive CHOP10 expression could lead 
to high preadipocytes proliferation (hyperplasia) and impair- 
ment of their terminal differentiation. RNase L activity could be 
crucial in the control of adipose tissue development and 
function during obesity and aging; based on our results we 
propose here a scheme of the role of RNase L in adipogenesis 
(Figure 8D).
Materials and Methods
MEFs isolation - cell viability. Five embryos from each mouse (WT and 
RNase L 7 mice, C57BL/6 strain) were collected aseptically at the stage of 16 days 
(the day of plug being the first day) in phosphate-buffered saline (PBS: 140 mM 
NaCI, 2mM KCI, 8mM Na2HPO4, 1.5 mM KH2PO4 (pH 7.4)). The limbs were cut 
and chipped to very small pieces. After digestion with 0.05% trypsin—EDTA solution, 
the cells were dissociated in two volumes of Dulbecco's modified eagle medium 
(DMEM, BioWhittaker, Lonza, Basel, Switzerland) containing 10% (V/V) of fetal calf 
serum (FCS, PAN Biotech, Dutscher, Brumath, France) by vigorous shaking. Then 
the cells were plated in tissue culture dishes with DMEM 10% (VA/) FCS. The cell line 
was immortalized by letting the cells pass the crisis with a total of 37 passages.34
Figure 7 Downregulation of CHOP10 mRNA with CHOP10 siRNA allows a better adipocyte differentiation of RNase L 7 -MEFs. (A) RNase L-MEFs were transfected 
with a siCHOP or a siCT, then cells were collected and mRNAs were analyzed, after RT, by q-PCR with specific primers for CHOP10 or EEF1 a (Supplementary Table 1). PCR 
products were analyzed on 1.2% agarose gel. Photographies of the gels are shown. (B) Cells were stained with oil red 0 to reveal lipids accumulation after 6 days of 
differentiation. RNase L z -MEFs transfected with siCT (a and c) and RNase L -MEFs transfected with siCHOP (b and d) were observed at a magnification of x 40. After 
staining with oil red 0, lipids were quantified by spectrophotometric analysis at 540 nm following elution of cell retained oil red 0 with ethanol. (e) Quantification of lipids in 
RNase L -MEFs transfected with siCT or siCHOP, 6 days after induction of differentiation in ADM. The amount of lipids in RNase L -MEFs transfected with siCT was set 
at 100%. Error bars refer to the S.D. obtained in four independent experiments conducted in duplicate. **P=0.003 RNase L-MEFs transfected with siCHOP compared 
with RNase L ' -MEFs transfected with siCT. (C) RNase L 7 -MEFs transfected with siCT or siCHOP were induced to differentiate during 6 days in ADM. Cells were fixed 
and then incubated with an antibody against perilipin (red; RNase L-MEFs transfected with siCT (a) and RNase L ' -MEFs transfected with siCHOP (b). DNA was stained 
with DAPI (blue). (D) RNase L 7 -MEFs transfected with siCT or siCHOP were treated ( + ) or not(-) 10 min at 37 °C with insulin after 6 days of differentiation. Total cellular 
extracts were analyzed by western blot with anti-P-Akt (Ser473), anti-Akt and anti-a-tubulin-specific antibodies. (E) Protein bands shown in (D) were quantified with the ImageJ 
software. Levels of P-Akt (Ser473)/Akt were corrected with corresponding a-tubulin levels, used as indicator of proteins loading. P-Akt (Ser473)/Akt rate in RNase L -MEFs 
transfected with siCT or siCHOP before insulin treatment was set at 1. Error bars refer to the S.D. obtained in four independent experiments. NS, non statistically significant 
P-Akt (Ser473)/Akt level after insulin treatment in differentiated RNase L 7 -MEFs transfected with siCHOP compared with differentiated RNase L-MEFs transfected 
with siCT
Cell viability was controlled for each cell line with the PrestoBlue Cell Viability 
Reagent kit (Life Technologies, Fisher Scientific, lllkirch, France) following the 
manufacturer instructions. PrestoBlue reagent was added in the cell culture 
medium, and the cells were incubated at 37 C for 30 min. Fluorescence intensity 
of the PrestoBlue reagent reduced by living cells was measured at 615nm 
wavelength (535 nm excitation wavelength) with an Infinite 200PRO TECAN 
(Lyon, France). Fluorescence level was normalized by cell number.
Cell culture - induction of adipocyte differentiation. WT-MEFs and
RNase L 7 -MEFs were cultured, as described previously, in the growth medium 
(GM): DMEM with 10% (V/V) FCS, 100 U/ml penicillin and 100 μg/ml streptomycin 
at 37'C.18
At 80% confluence, cells were switched to adipocyte differentiating medium 
(ADM): GM supplemented with 0.5 mM 3-isobutyl-1-methylxanthine, 1 μM 
dexamethasone and 10 μM insulin (all from Sigma-Aldrich, Saint-Quentin Fallavier, 
France) for 2 days. Cells were then incubated in fresh ADM for 2 supplementary 
days and then the medium was changed to GM for 2 days.19
For insulin response, cells were treated or not with insulin (1 nmol) for 
10 min at 37'C. Cells were then washed twice with PBS and lysed in sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer
(300 mM Tris (pH 8.9), 5% (WA/) SDS, 750 mM β-mercaptoethanol, 20% (V/V) 
glycerol and bromophenol blue) for proteins analysis by western blot.
Oil red O labeling - immunofluorescence. Adipogenic cell phenotype 
was characterized by specific oil red O staining of lipids.35 Cells were observed with 
a Nikon AZ100 and TIFF images were captured with a Nikon Digital Camera (DXM 
1200c; Champigny sur Marne, France) with ACT-1C program for the control of 
DXM 1200C platform. Lipids accumulation was quantified by spectrophotometric 
analysis at 540 nm after eluting the oil red O retained in the cells with ethanol. 
Optical density was measured with an Infinite 200PRO TECAN.
For immunofluorescence analysis, cells were fixed in 3.7% (V/V) formalin for 
10 min and permeabilized with PBS-Triton X100 0.5% (V/V) at room temperature for 
5 min. After blocking with 10% (MN) FCS in PBS, cells were incubated with an anti- 
perilipin or an anti-aP2/Fabp4 antibody (both from Cell Signaling, Ozyme, Saint-Quentin 
Yvelines, France) for 1 h at room temperature. Cells were then washed and incubated 
with a donkey anti-rabbit secondary antibody conjugated to tetramethylrhodamine- 
5,6-isothiocyanate (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1 h at 
room temperature. Cells were observed at room temperature with an Imager Ml 
Zeiss (Le Pecq, France), and TIFF images were captured with an Axiocam MRm 
Zeiss and the Axiovision 4.7 (05-2008) program.
Figure 8 RNase L ' mice present impairments of adipogenesis. (A) Adipose tissue sections from male WT and RNase L ' mice (a and b, respectively) and female WT 
and RNase L mice (c and d, respectively) were stained with H&E. (e) Relative number of adipocytes from male and female WT (black bars) and RNase L ' mice (white 
bars). Number of adipocytes from WT male mouse was set at 100%. sSP< 0.001 number of adipocytes in male and female RNase L; mice compared with adipocytes 
number in male and female WT mice, respectively. (f) Average size of adipocytes from abdominal adipose tissue from male and female WT (black bars) and RNase L' 
mice (white bars). sSP<0.001 average size of adipocytes in male and female RNase L; mice compared with adipocytes size in male and female WT mice, respectively. 
(B) Eight pairs of age- and gender-matched WT and RNase L ' mice were maintained for 18 months and fed with a chew diet. The average body weight was 65.8 ± 5.9 g for 
RNase L z mice and 54.4 ± 3.3 g for WT mice (P=0.056). (C) H&E staining of the liver (a and b) and kidney (c and d) sections from WT and RNase L; mice. (D) Scheme 
of potential role of RNase L during adipogenesis. In RNase L; mouse, CHOP10 expression is maintained after induction of differentiation. Consequently, clonal expansion 
of preadipocytes is more important in RNase L mice that leads to an important adipose tissue development but with less differentiated adipocytes. These adipocytes are not 
able to stock correctly lipids as do WT mouse adipocytes
Reverse transcription (RT), semi-quantitative PCR and q-PCR.
Total RNAs were isolated using TRIzol (Invitrogen, Fisher Scientific). To avoid genomic 
DNA contamination and amplification during PCR, RNAs were treated with DNase- 
RNase free (Euromedex, Souffelweyersheim, France) before RT. cDNAs were 
generated by RT with oligo-(dT) primers and the Moloney murine leukemia virus 
(M-MLV) Reverse Transcriptase (Jena Bioscience, Euromedex). Briefly, 5/ig of total 
RNAs were denatured at 70 °C and then reverse transcribed at 42 °C for 120 min 
following the manufacturer instructions.
Semi-quantitative PCR of the cDNAs was performed using a Biometra 
thermocycler (LABGENE, Archamps, France) in a total volume of 25 μI. Cycle 
number was 32. Amounts of cDNA were adjusted for each primer pair to be in the
linear range amplification and to give the same quantity of amplified cDNA with 
eukaryotic elongation factor 1a (EEF1a) primers. PCR products were visualized in 
1.2% agarose gel and stained with ethidium bromide. Photographies of the gels 
were captured as TIFF files with a Vilber Lourmat camera and Ecapt program 
(both from VWR, Fontenay-sous-bois, France).
To quantify genes expression allowing a comparison between WT-MEFs and 
RNaseL -MEFs or V-RNaseL -MEFs and Hu-RNaseL -MEFs. cDNAs were 
used as templates in SYBR Green I Master real-time q-PCR assays on a 
LightCycler 480 (Roche Diagnostics, Meylan, France), in a total volume of 10μI. 
Cycle number was 45. Sample data were analyzed according to the comparative 
cycle threshold method and were normalized by stable reference gene of EEF1u.
Gene sequences for primer design were obtained from the NCBI Reference 
Sequences database. Primers were chosen using the Primer3 and the LightCycler 
Probe Design (Roche) softwares. When possible, forward and reverse primers were 
designed on different exon sequences. Primers sequences are provided in 
Supplementary Table 1.
mRNPs immunoprecipitation. We used the protocol described by 
Sanchez ef a/.36 with some modifications. Briefly, confluent WT-MEFs and 
RNase L ' -MEFs were lysed with IPP50 buffer (10 mM Tris-HCI (pH 8), 150 mM 
NaCI,) without NP40 and supplemented with 2mM EDTA and 10/rg/ml aprotinin, 
150/rg/ml leupeptin, 1 mM phenylmethanesulfonyl fluoride and 80U RNaseOut 
(Invitrogen). Cell extracts were centrifuged at 10000 x g. Supernatants (2 mg of 
proteins) were incubated with protein A-sepharose equilibrated in the same 
modified IPP50 buffer, and no antibody, mouse monoclonal anti-α-tubulin (Sigma- 
Aldrich) or mouse monoclonal anti-RNase L antibody (Abcam, Paris, France). After an 
overnight incubation at 4 °C with gentle shaking, protein A-sepharose beads were 
centrifuged and washed three times with ice-cold-modified IPP50 buffer. The pellet was 
separated in two fractions. One fraction was analyzed for RNase L protein content 
by western blot as described below. RNAs were extracted from the other fraction 
by adding TRIzol (1 ml) to the beads and following the manufacturer instructions 
(Invitrogen). Glycogen (10 μg) was added to ease RNA precipitation with 
isopropanol. cDNA was generated from total extracted RNA by RT with oligo- 
(dT) primers and the M-MLV Reverse Transcriptase (Jena Bioscience) as described 
above. 2.5μl of RT product was amplified with specific CHOP10 primers 
(Supplementary Table 1) by q-PCR following the manufacturer instructions (Roche) 
with a LightCycler 480 as described previously.
mRNA stability. WT-MEFs and RNase L-MEFs were plated in GM and, at 
confluence, cells were treated with actinomycin D (5 /rg/ml) for 0,1,2,4 or 6 h. Then 
RNAs were extracted and analyzed after RT by semi-quantitative PCR as described 
above. Following agarose gel electrophoresis, pictures of the gels were saved as 
TIFF files with a Vilber Lourmat camera and Ecapt program. cDNAs were also 
analyzed by q-PCR following the manufacturer instructions (Roche) with a 
LightCycler 480 as described above.
Western blot assay. At confluence, cells were switched to differentiation 
medium as indicated above. Cells were then collected in SDS-PAGE buffer at 
confluence or after 6 days in ADM. Protein extracts were incubated with benzonase 
(Sigma-Aldrich) 15 min at 37 °C before western blot analysis. Nitrocellulose 
membranes were then incubated in blocking buffer for fluorescent western blotting 
(Odyssey Infrared Imaging System LI-COR Biosciences, ScienceTec, Courtabceuf, 
France) for 1 h and incubated with a rabbit polyclonal anti-RLI antibody (Novus 
Biological, Interchim, Montlucon, France), or a mouse monoclonal anti-Hu-RNase L 
(Abcam) or a rabbit polyclonal anti-mouse RNase L (Santa Cruz), or a rabbit 
polyclonal anti-phospho-Akt (Ser473) or a rabbit polyclonal anti-Akt (both from Cell 
Signaling), or a mouse monoclonal anti-α-tubulin (Sigma-Aldrich) in the same buffer 
overnight at 4 °C. Membranes were washed in PBS supplemented with 0.05% (V/V) 
Tween 20 then with PBS alone and incubated for 45 min at room temperature with a 
donkey anti-rabbit or anti-mouse conjugated to IRDye 700DX or IRDye800 
(Rockland, Tebu-Bio). Specific proteins were visualized with a LI-COR Odyssey 
Biosciences Imaging System. Protein bands were quantified by image analysis with 
the ImageJ software (http://rsbweb.nih.gov/ij/index.html).
Glucose uptake. A fluorescent glucose analog, 6-(N-(7-nitrobenz-2-oxa-1, 
3-diazol-4-yl) amino)-2-deoxy-glucose (6-NBDG, Molecular Probes, Fisher Scientific), 
was used to measure glucose uptake in WT-MEFs, RNase L ' -MEFs. V-RNase L 7 - 
MEFs and Hu-RNase L 7 -MEFs.37 After differentiation, cells were incubated 10 min 
with or without insulin (1 nmol) then medium was changed to glucose-free DMEM and 
6-NBDG (300 μM) was then added to all cells for 45 min at 37 °C. Cells were thoroughly 
washed to remove all exogenous fluorescent glucose analog, and fluorescence intensity 
of 6-NBDG was measured at 540 nm wavelength (465 nm excitation wavelength) with 
an Infinite 200PRO TECAN. Fluorescence level was normalized with cell number.
ROS production in WT-MEFs and RNase L 7 -MEFs. ROS level was 
measured using the nitroblue tetrazolium (NBT) assay (Sigma-Aldrich).38 Cells were 
incubated for 90 min in DMEM 0.2% (W/V) NBT. Produced formazan was then 
dissolved in 50% (V/V) acetic acid and the absorbance was determined at 560 nm 
with an Infinite 200PRO TECAN. Optical density values were normalized by 
protein levels.
Ectopic expression of Hu-RNase L in RNase L 7 -MEFs. The
coding sequence of Hu-RNase L cDNA was subcloned in pcDNA3neo (Invitrogen) 
by the standard procedures.39 RNase L-pcDNA3neo or the empty vector 
pcDNA3neo were transfected into RNase L 7 -MEFs with JetPEI (Qbiogene, 
lllkirch, France) following the manufacturer instructions. As observed previously, 
the yield of transfection was low,40 so transfectants were selected by culturing 
cells in the presence of 1 mg of G418 (Gibco-BRL, Fisher Scientific) per ml of 
cell culture medium. The polyclonal cell population expressing the transfected 
Hu-RNase L cDNA was named Hu-RNase L 7 -MEFs; the polyclonal cell popula- 
tion expressing the transfected empty vector was named V-RNase L 7 -MEFs.
siCHOP and siCT transfection. The siRNA duplexes have been designed 
and manufactured by Qiagen (Courtabceuf, France).
siCHOP sense: (5'-GGAAGUGCAUCUUCAUACA-3')dTdT: siCHOP antisense: 
(5'-UGUAUGAAGAUGCACUUCC-3')dTdT; siCT: sense (5'-UUCUCCGAACGUG 
UCACGU-3')dTdT; siCT antisense: (5'-ACGUGACACGUUCGGAGA-3')dTdT. 
siRNAs were transfected into RNase L 7 -MEFs with HiPerFect (Qiagen) following 
the manufacturer instructions.
Statistical analysis. Means ± S.D.’s were calculated and statistical analyses 
using the Holm-Sidak method were performed with the SigmaStat software. 
Significant differences between two groups are considered for *P< 0.05, **P<0.01 
and§P<0.001.
Histological analysis of white adipose tissue from WT and RNase 
L 7 mice. Abdominal fat pad was removed from each mouse (two females and 
two males, 21 weeks aged) and fixed in 10% formalin. Fixed specimens were 
embedded in paraffin. Sections were then stained with hematoxylin and eosin 
(H&E). Adipocytes were counted in four different sections for each mouse.
Phenotype of mouse RNase L 7 . Eight pairs of age-matched WT and 
RNase L 7 male mice (C57BL76 strain) were maintained for 18 months and fed 
with chew diet. Food intake was similar for both types of mice. The average body 
weight was measured in WT mice (five survived) and in RNase L (six survived). 
For histological analyses of the liver and kidney, tissues were fixed in formalin and 
then embedded in paraffin. Sections were deparaffinized, rehydrated and stained 
with H&E.
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